This episode of AI Meets Life Sci explores the potential for data-driven innovation in healthcare, through conversations with leaders at Microsoft and 1910 Genetics.

In the first segment, Elena Bonfiglioli, Global Business Leader for Healthcare, Pharma and Life Sciences at Microsoft, discusses the significance of computation, an essential element of AI investments, in enhancing R&D productivity in healthcare. She emphasizes the need for new approaches to drug development, including shorter clinical trial timelines and the shift toward more efficient R&D. Bonfiglioli also highlights the importance of multimodal data in research and development. In addition, speaks to the integral role of computational methods in drug development, emphasizing how they augment our disease understanding and can help with clinical trial design.

In the second segment, Jen Nwankwo, PhD, Founder & CEO of 1910 Genetics - a Y Combinator and Sam Altman-backed startup, shares the innovation strategies around drug discovery. She details their problem-first approach, leading to an integrated, modality-agnostic drug discovery tech stack. Dr. Nwankwo highlights the use of Azure Quantum Elements in accelerating molecular simulations, positioning 1910 Genetics uniquely in designing both small and large molecules. Their global approach to accessible drug discovery through strategic partnerships is emphasized.

Join us for the next episode of AI Meets Life Sci, featuring an exclusive interview with Ben Newton, Chief Digital Officer and GM of Oncology at GE Healthcare.

Thank you to our contributors, some of whom include Catalyze Healthcare and SmartTRAK Business Intelligence, for providing invaluable support.
Tune in and subscribe to AI Meets Life Sci on all major podcast channels and follow youtube.com/@DeviceTalks or AI Meets Life Sci YouTube Podcast to ensure you never miss an episode. 

WATCH, LISTEN, and READ: https://linktr.ee/AIMeetsLifeSci. Thank you for supporting AI Meets Life Sci!

Read Now: www.drugdiscoverytrends.com/microsoft-1910-genetics-data-hidden-gems

Discovering data’s hidden gems with Microsoft and Sam Altman-backed 1910 Genetics

This episode of AI Meets Life Sci offers a comprehensive look at the ways AI is poised to upend the pharmaceutical industry. It features an in-depth keynote interview with Helen Merianos, Head of Sanofi's R&D Portfolio Strategy, who provides an inside look into Sanofi's commitment to go "all-in" on AI and data science. Merianos discusses the use of Sanofi's proprietary plai app – an AI-enabled smartphone app that draws from over a billion data points – and its role in establishing a data-driven culture across the company.

Additionally, the episode features Michelle Longmire, MD, Co-Founder and CEO of Medable, who discusses the use of generative AI in automating and accelerating clinical trial technology deployment timelines. These applications could cut some timelines in half. Longmire envisions AI's potential to drastically accelerate a development process. “Say there's 10,000 uncured or poorly suboptimally treated human diseases.” At the current pace of drug development, it might take about 200 years to create treatments for those conditions. “Imagine if we could 10x that,” Longmire says.

Join us for the next episode of AI Meets Life Sci, where we sit down with Ha Hong, PhD, Chief Artificial Intelligence Officer, Endoscopy at Medtronic.

Thank you to our sponsors Catalyze Healthcare and SmartTRAK Business Intelligence, for providing invaluable support.
catalyzehealthcare.com
smarttrak.com

Tune in and subscribe to AI Meets Life Sci on all major podcast channels and follow youtube.com/@DeviceTalks or AI Meets Life Sci YouTube Podcast to ensure you never miss an episode.

WATCH, LISTEN, and READ. Thank you for supporting AI Meets Life Sci!

Sanofi races to the AI forefront in Big Pharma; Plus, Medable's big promises for clinical trials

AI Meets Life Sci explores the transformative role of AI and ML in the life sciences. The series zeroes in on major obstacles and opportunities in healthcare, presenting insights from Big Pharma, medtech OEMs, and Tech Giants, shaping the healthcare landscape and leading to better health outcomes. 

#medtech #pharma #technology #artificialintelligence #ai #machinelearning #videopodcast #podcast #medicaltechnology #pharmaceutical 

This video podcast is powered by DeviceTalks and is a collaboration between DeviceTalks and Drug Discovery & Development. Co-Hosts: Kayleen Brown, Managing Editor, DeviceTalks and Brian Buntz, Pharma Editor, Drug Discovery & Development. 

www.devicetalks.com/AI

Sanofi races to the AI forefront in Big Pharma; Plus, Medable's big promises for clinical trials

AI Meets Life Sci

Related tracks